tradingkey.logo
tradingkey.logo
Search

Establishment Labs Holdings Inc

ESTA
Add to Watchlist
87.210USD
+0.200+0.23%
Close 06/24, 16:00ETQuotes delayed by 15 min
2.57BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-24
Previous score
8.44
Change
0
The current earnings forecast score of Establishment Labs Holdings Inc is 8.44, ranking 32 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 75.00, with a high of 85.00 and a low of 62.00.

Analyst Rating

Based on 9 analysts
Buy
Current Rating
92.125
Target Price
+8.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Establishment Labs Holdings Inc
ESTA
9
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
1
2
3
...
24

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Establishment Labs Holdings Inc's expected revenue for the next quarter?

Establishment Labs Holdings Inc's expected revenue is 65.71M.

What is Establishment Labs Holdings Inc's price target?

Analysts forecast that Establishment Labs Holdings Inc's price target is USD 75.00, with the highest forecast at USD 85.00 and the lowest forecast at USD 62.00.

How have Establishment Labs Holdings IncESTA's recent earnings per share performed?

The market expectation was USD -0.45, while Establishment Labs Holdings IncESTA's earnings per share (EPS) for the previous quarter was USD -0.09. EPS for the next quarter is expected at USD -0.34.

What is the analyst rating for Establishment Labs Holdings Inc?

Based on the ratings of Establishment Labs Holdings Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI